Previous work using BLUES has shown success in accelerating sampling of ligand binding modes in the simple model systems of toluene and iodotoluene bound to the T4 lysozyme L99A mutant. Here, we are interested in applying BLUES to a more complex target with pharmaceutical relevance to evaluate its utility beyond a simple model system.